Market revenue in 2023 | USD 140.2 million |
Market revenue in 2030 | USD 163.0 million |
Growth rate | 2.2% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche Holding AG ADR, Qiagen NV, Siemens Healthineers AG ADR, Becton Dickinson & Co, Illumina Inc, Epigenomics AG, Koninklijke Philips NV, FUJIFILM Holdings Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liver cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 61.13% in 2023. Horizon Databook has segmented the Middle East & Africa liver cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East and Africa liver cancer diagnostic market growth can be attributed to a number of initiatives undertaken by the government to enable early diagnosis and treatment of liver cancer.
Furthermore, increasing risk of liver cancer due to high prevalence of HBV and HCV infections in countries such as South Africa is also expected to drive demand for liver cancer diagnostics solutions. However, low awareness about diseases, uncertain reimbursement scenarios, and lack of skilled professionals in some MEA countries is expected to be a major threat to market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa liver cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa liver cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account